Zusammenfassung
Ovarielle Funktionsstörungen, die mit einer Anovulation einhergehen, machen ca. 35–40% der Ursachen einer bestehenden Ehesterilität aus. Folgerichtig stehen sie im Vordergrund der Sterilitätsbehandlung. Klinisch können sich diese Störungen in einer Vielzahl von Symptomen äußern. Diese reichen von der einfachen Regeltempostörung über die Oligomenorrhö bis zur primären oder sekundären Amenorrhö, zum Teil einhergehend mit weiteren Symptomen (s. Übersicht).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Adashi EY (1990) Ovulation induction:Comiphene citrate. In: Seibel MM (ed) Infertility:a comprehensive text. Appleton & Lange, Norwalk/CT
Adashi EY (1994) Clomiphene citrate. In: Seibel MM, Blackwell RE (eds) Ovulation induction. Raven, New York, pp. 95
Ash RH, Greenblatt RB (1976) Update on the safety and efficacy of clomiphene citrate as a therapeutic agent. J Reprod Med 17:175
Ash R, Irvey G, Goldsman M, Frederick JL, Stone SC, Balmaceda JP (1994) The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome. Hum Reprod 8:1015
Bauer O, Diedrich K (1996) Komplikationen der assistierten Reproduktion. Gynäkologe 29:464
Baumann P, Felberbaum R, Diedrich K (1996) Schwangerschaft and Geburt nach In-vitroFertilisation. Gynäkologe 29:507
Boue JG, Boue A (1973) Increased frequency of chromosomal anomalies in abortions after induced ovulation. Lancet I-679
Chappal S, Kelton C, Nugent N (1992) Expression of human gonadotropins by recombinant DNA methods. In: Genazzi A, Petraglia F (eds) Proceedings of the 3rd World Congress on Gynecological Endocrinology. Parthenon, Camforth, pp 179
Daya S (1995) Menopausal gonadotrophin for in vitro fertilization; results of a metaanalysis. Horm Res 43:224
De Geyter C, De Geyter M, Castro E, Bals-Pratsch M, Nieschlag E, Schneider HPG (1996) Experience with transvaginal ultrasound-guided aspiration of supernumerary follicles for the prevention of multiple pregnancies after ovulation induction and intrauterine insemination. Fertil Steril 65:1163
Dekel N (1988) Spatial relationship of follicular cells in the control of meiosis. In: Haseltine FP, First NL (eds) Progress in clinical and biological research. Meiotic inhibition:molecular control of meiosis. Liss, New York
Delbaere A, Bergmann PJM, Gervy-Decoster C, Staroukine M, Englert Y (1994) Angiotensin II immunoreactivity is elevated in ascites during severe ovarian hyperstimulation syndrome; implications for pathophysiology and clinical management. Fertil Steril 62:731–737
Diedrich K (1990) In-Vitro-Fertilisation and Embryotransfer. Gegenwärtiger Stand. Fertilität 3:93
Diedrich K, Diedrich C, Santos E et al. (1994) Suppression of the endogenous luteinizing hormone surge by the gonadotropin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum Reprod 9:788
Diedrich K, Felberbaum R, Baumann P (1996) Assistierte Reproduktion-ein Überblick. Gynäkolog 29:413
Dufau HL, Catt RJ, Tsuruhara T (1971) Retention of in vitro biological activities by desialytated human luteinizing hormone and chorionic gonadotropin. Biochem Biophys Res Commun 44:1022
Edwards RG, Lobo R, Bouchard P (1996) Time to revolutionize ovarian stimulation. Hum Reprod 11:917
Felberbaum R, Diedrich K (1996) Klinischer Einsatz der GnRH-Analoga im Rahmen der Sterilitätstherapie:Agonisten und Antagonisten. Gynäkologe 29:420
Felberbaum R, Küpker W, Neulen J, Diedrich K (1996) Einsatz des rekombinanten humanen follikelstimulierenden Hormons (rec.FSH) in der Sterilitätstherapie:Informationen für die Praxis. Frauenarzt 37:1192
Fernandez L, Twickler J, Mead A (1985) Neovascularization produced by angiotensin II. J Lab Clin Med 105:219–223
Golan A, Ron-El R, Herman A, Weintraub Z, Soffer Y, Caspi E (1989) Ovarian hyperstimulation syndrome:an update review. Obstet Gynecol Sury 44:430–440
Greenblatt RB, Barfield WE, Jungck EC, Ray AW (1961) Induction of ovulation with MAL/ 41. JAMA 178:101
Hassiakos D, Toner JP, Muasher SJ, Jones HW Jr (1990) Implantation and pregnancy rats in relation to oestradiol and progesterone profiles in cycles with and without the use of gonadotrophin-releasing hormone agonist suppression. Hum Reprod 5:1004
Hoff YD, Quigley ME, Yen SCC (1983) Hormonal dynamics at midcycle:a reevaluation. J Clin Endocrinol Metab 57:892–896
Hoffmann D, Lobo RA (1985) Serum dehydroepiandrosterone sulfate and the use of clomiphene citrate in anovulatory women. Fertil Steril 43:196
Homburg R, Giroud D, Howles C, Loumaye E (1995) Efficacy of recombinant human follicle hormone Gonal-F for inducing ovulation in WHO II group anovulatory patients. Preliminary results of a comparative multicentre study. Front Endocrinol 4:463
Howles CM, Macnamee MC, Edwards RG, Goswamy R, Steptoe PC (1986) Effect of high tonic levels of luteinizing hormone on outcome of in-vitro fertilization. Lancet II:521–522
Kleinstein J (1991) Das Hyperstimulationssyndrom. Gynäkologe 24:130–135
Lehmann F, Breckwoldt M (1991) Gonadotropine:drei Jahrzehnte Entwicklung. HMG-Behandlung in der Praxis. Enke, Stuttgart ( Bücherei des Frauenarztes, Bd. 39 )
Lemay A, Maheux R, Faure N, Jean C, Fazekas ATA (1984) Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis. Fertil Steril 41:863
Loumaye E, Campbell R, Salat-Baroux J (1995) Human follicle-stimulating hormone produced by recombinant DNA technology:a review for clinicians. Hum Reprod Update 1:188
Lunenfeld B, Blankstein J, Ron-El R (1987) Short and long term survey of patients treated with HMG/HCG and follow-up of offspring. In: Genazziani AR, Volpe A, Fachinetti F (eds) Proceedings of the first international congress on gynecological endocrinology, p 459
Lunenfeld B, Insler V, Glezerman M (1992) Diagnosis and treatment of functional infertility. Blackwell, Berlin
Navot D, Margalioth EJ, Laufer N, Birkenfeld A, Relou A, Schenker JG (1987) Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome. Fertil Steril 48:57–61
Olivennes F, Rufat P, Andrè B, Pourade A, Quiros MC, Frydman R (1993) Increased risk of complication observed in singleton pregnancies resulting from in-vitro-fertilization (IVF) does not seem to be related to the IVF method itself. Hum Reprod 8:1297
Palopoli FP, Feil VJ, Allen RE, Holtkamp DE, Richardson A Jr (1967) Substituted aminoalkoxytriarylhaloethylenes. J Med Chem 10:84
Shoham Z (1993) Low-dose protocol of follicle stimulating hormone for induction of ovulation in patients with polycystic ovary syndrome:the hypothesis, etiology and clinical experience. In: Lunenfeld B (ed) FSH alone in ovulation induction. Parthenon, New York, pp 29
Shoham Z, Zosmer A, Insler V (1991) Early miscarriage and fetal malformations after induction of ovulation (by clomiphene citrate and/or human menotropins), in vitro fertilization and gamete intrafallopian transfer. Fertil Steril 55:1
Smitz J, Devroey P, Faguer B, Bourgain C, Camus M, Van Steirteghem AC (1992) A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement. Hum Reprod 7:168–175
Stanger JD, Yovich JL (1985) Reduced in vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. BJ Obstet Gynaecol 92:385–393
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Felberbaum, R., Ortmann, O., Weiss, J., Diedrich, K. (1998). Ovarielle Stimulation: Möglichkeiten und Komplikationen. In: Diedrich, K. (eds) Weibliche Sterilität. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58738-2_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-58738-2_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63704-9
Online ISBN: 978-3-642-58738-2
eBook Packages: Springer Book Archive